Estudos clínicos abertos, por área e subespecialidade
Dados oficiais do ClinicalTrials.gov, organizados por área clínica, subespecialidade e localização.
Sua instituição quer participar de estudos de Oncologia?
A ClinPesq ajuda centros de pesquisa a se prepararem para participar de estudos como esses: diagnóstico de viabilidade, implantação e treinamento da equipe.
347 estudos recrutando encontrados no Brasil para Oncologia. Mostrando os mais recentes.
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
Huntsville, United States e mais 234 localis
Ver estudo completoA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Rheumatoid Arthritis
Peoria, United States e mais 63 localis
Ver estudo completoA Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phoenix, United States e mais 237 localis
Ver estudo completoMK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
Non-small Cell Lung Cancer
Ciudad Autónoma de Buenos Aires, Argentina e mais 105 localis
Ver estudo completoA Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Non-small Cell Lung Cancer
Birmingham, United States e mais 211 localis
Ver estudo completoA Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Non-small Cell Lung Cancer
Lincoln, United States e mais 79 localis
Ver estudo completoA Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma
Springdale, United States e mais 69 localis
Ver estudo completoA Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Gilbert, United States e mais 191 localis
Ver estudo completoA Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Non-small Cell Lung Cancer
Sacramento, United States e mais 92 localis
Ver estudo completoA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Tucson, United States e mais 327 localis
Ver estudo completoA Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Carcinoma, Non-Small-Cell Lung
Gilbert, United States e mais 241 localis
Ver estudo completoA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
Phoenix, United States e mais 345 localis
Ver estudo completoPhase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Birmingham, United States e mais 228 localis
Ver estudo completoA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Tucson, United States e mais 329 localis
Ver estudo completoA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
New Haven, United States e mais 190 localis
Ver estudo completoSacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phoenix, United States e mais 219 localis
Ver estudo completoA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Little Rock, United States e mais 268 localis
Ver estudo completoA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate Cancer, Prostatic Neoplasms
Phoenix, United States e mais 297 localis
Ver estudo completoROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Springdale, United States e mais 201 localis
Ver estudo completoSubstudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Esophageal Squamous Cell Carcinoma
Pittsburgh, United States e mais 47 localis
Ver estudo completoLong-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Tucson, United States e mais 781 localis
Ver estudo completoDados fornecidos pelo ClinicalTrials.gov, mantido pela National Library of Medicine (EUA). A ClinPesq organiza a busca; os detalhes oficiais de cada estudo estão no site original.